Company intelligence
Interrad Medical
SecurAcath provides improved catheter securement by reducing complications and cost of care
About Interrad Medical
WHAT WE DO: Interrad Medical has developed a revolutionary new method for securing catheters that does not require adhesives or sutures called the SecurAcath Subcutaneous Engineered Stabilization Device. HOW IT WORKS: The unique design of the SecurAcath device secures catheters right at the insertion site using small, blunt securement feet placed in the subcutaneous tissue just beneath the skin. WHY IT'S BETTER: SecurAcath can help maintain access for the entire duration of therapy. - Never needs replacing - Significantly reduces risk of catheter-related infection - Dramatically reduces catheter dislodgement - Eliminates line migration and pistoning - Confident dressing changes - Improves catheter site cleaning - Eliminates suture needle stick risk - Reduces catheter complications - Improves vessel health and preservation - Lower total cost of patient care Securacath is the new standard of care for catheter securement. Complete information available on our website: www.securacath.com email us at info@securacath.com
Verified activity
Signals from Interrad Medical
4 published signals
Presence & Recognition
Interrad Medical is hosting a live webinar on Wednesday, September 9, at 3pm featuring Pediatric Critical Care Experts Dr. Duncan and Dr. Lanier discussing innovative applications of SecurAcath beyond PICCs.
Reported by Laura Novelli Krick
Research & Knowledge
Interrad Medical published a study conducted at the University of Arkansas for Medical Sciences (UAMS) showing that SecurAcath reduced the risk of Central Line-Associated Bloodstream Infections (CLABSI) by 74% compared to adhesive securement devices.
Reported by Laura Novelli Krick
Presence & Recognition
Interrad Medical is hosting a live webinar on Wednesday, September 9th featuring Pediatric Critical Care Experts Dr. Duncan and Dr. Lanier discussing innovative applications of SecurAcath beyond PICCs.
Reported by Laura Novelli Krick
Research & Knowledge
Interrad Medical published a study conducted at the University of Arkansas for Medical Sciences (UAMS) showing that SecurAcath reduced the risk of Central Line-Associated Bloodstream Infections (CLABSI) by 74% compared to adhesive securement devices.
Reported by Laura Novelli Krick